In particular, some variants in the promoter region of plasminogen activator inhibitor-1 (also known as SERPINE1 or PAI-1), which regulates fibrinolysis, are thought to be associated with CAD sensitivity [8,9]. Here, SERPINE1 is linked to coronary artery disorder.